 | • レポートコード：QYR2104Z4215 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肥満治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術＆インプラント装置、薬物療法、食事療法、その他）、用途別市場規模（子供、大人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肥満治療の市場動向 ・企業の競争状況、市場シェア ・肥満治療の種類別市場規模（手術＆インプラント装置、薬物療法、食事療法、その他） ・肥満治療の用途別市場規模（子供、大人） ・肥満治療の北米市場規模2016-2027（アメリカ、カナダ） ・肥満治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肥満治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肥満治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・肥満治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（NutriSystem, Inc. (U.S.)、Kellogg Company (U.S.)、Ethicon, Inc. (U.S.)、Medtronic (U.S.)、F. Hoffmann-La Roche (Switzerland)、Atkins Nutritionals, Inc. (U.S.)、Herbalife Ltd. (U.S.)、Covidien plc (U.S.)、Apollo Endosurgery (U.S.)、Amer Sports (Finland)、Johnson Health Technology, Ltd. (Taiwan)、Cybex International (U.S.)、USGI Medical (U.S.)、Olympus Corporation (Japan)、Brunswick Corporation (U.S.)、Technogym SpA (Italy)） ・結論 |
Market Analysis and Insights: Global Obesity Treatment Market
The global Obesity Treatment market size is projected to reach US$ 11930 million by 2026, from US$ 4912 million in 2019, at a CAGR of 13.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Obesity Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Obesity Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Obesity Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Obesity Treatment market.
Global Obesity Treatment Scope and Market Size
Obesity Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Segment by Application
Children
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical & Implant Devices
1.2.3 Medication Therapy
1.2.4 Dietary
1.2.5 Other
1.3 Market by Application
1.3.1 Global Obesity Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Obesity Treatment Market Perspective (2016-2027)
2.2 Obesity Treatment Growth Trends by Regions
2.2.1 Obesity Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Obesity Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Obesity Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Obesity Treatment Industry Dynamic
2.3.1 Obesity Treatment Market Trends
2.3.2 Obesity Treatment Market Drivers
2.3.3 Obesity Treatment Market Challenges
2.3.4 Obesity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Obesity Treatment Players by Revenue
3.1.1 Global Top Obesity Treatment Players by Revenue (2016-2021)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Obesity Treatment Revenue
3.4 Global Obesity Treatment Market Concentration Ratio
3.4.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2020
3.5 Obesity Treatment Key Players Head office and Area Served
3.6 Key Players Obesity Treatment Product Solution and Service
3.7 Date of Enter into Obesity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Obesity Treatment Breakdown Data by Type
4.1 Global Obesity Treatment Historic Market Size by Type (2016-2021)
4.2 Global Obesity Treatment Forecasted Market Size by Type (2022-2027)
5 Obesity Treatment Breakdown Data by Application
5.1 Global Obesity Treatment Historic Market Size by Application (2016-2021)
5.2 Global Obesity Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Obesity Treatment Market Size (2016-2027)
6.2 North America Obesity Treatment Market Size by Type
6.2.1 North America Obesity Treatment Market Size by Type (2016-2021)
6.2.2 North America Obesity Treatment Market Size by Type (2022-2027)
6.2.3 North America Obesity Treatment Market Size by Type (2016-2027)
6.3 North America Obesity Treatment Market Size by Application
6.3.1 North America Obesity Treatment Market Size by Application (2016-2021)
6.3.2 North America Obesity Treatment Market Size by Application (2022-2027)
6.3.3 North America Obesity Treatment Market Size by Application (2016-2027)
6.4 North America Obesity Treatment Market Size by Country
6.4.1 North America Obesity Treatment Market Size by Country (2016-2021)
6.4.2 North America Obesity Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Obesity Treatment Market Size (2016-2027)
7.2 Europe Obesity Treatment Market Size by Type
7.2.1 Europe Obesity Treatment Market Size by Type (2016-2021)
7.2.2 Europe Obesity Treatment Market Size by Type (2022-2027)
7.2.3 Europe Obesity Treatment Market Size by Type (2016-2027)
7.3 Europe Obesity Treatment Market Size by Application
7.3.1 Europe Obesity Treatment Market Size by Application (2016-2021)
7.3.2 Europe Obesity Treatment Market Size by Application (2022-2027)
7.3.3 Europe Obesity Treatment Market Size by Application (2016-2027)
7.4 Europe Obesity Treatment Market Size by Country
7.4.1 Europe Obesity Treatment Market Size by Country (2016-2021)
7.4.2 Europe Obesity Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Obesity Treatment Market Size (2016-2027)
8.2 Asia-Pacific Obesity Treatment Market Size by Type
8.2.1 Asia-Pacific Obesity Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Obesity Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Obesity Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Obesity Treatment Market Size by Application
8.3.1 Asia-Pacific Obesity Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Obesity Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Obesity Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Obesity Treatment Market Size by Region
8.4.1 Asia-Pacific Obesity Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Obesity Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Obesity Treatment Market Size (2016-2027)
9.2 Latin America Obesity Treatment Market Size by Type
9.2.1 Latin America Obesity Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Obesity Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Obesity Treatment Market Size by Type (2016-2027)
9.3 Latin America Obesity Treatment Market Size by Application
9.3.1 Latin America Obesity Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Obesity Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Obesity Treatment Market Size by Application (2016-2027)
9.4 Latin America Obesity Treatment Market Size by Country
9.4.1 Latin America Obesity Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Obesity Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Obesity Treatment Market Size (2016-2027)
10.2 Middle East & Africa Obesity Treatment Market Size by Type
10.2.1 Middle East & Africa Obesity Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Obesity Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Obesity Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Obesity Treatment Market Size by Application
10.3.1 Middle East & Africa Obesity Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Obesity Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Obesity Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Obesity Treatment Market Size by Country
10.4.1 Middle East & Africa Obesity Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Obesity Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Details
11.1.2 NutriSystem, Inc. (U.S.) Business Overview
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
11.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.1.5 NutriSystem, Inc. (U.S.) Recent Development
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Details
11.2.2 Kellogg Company (U.S.) Business Overview
11.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
11.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.2.5 Kellogg Company (U.S.) Recent Development
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Details
11.3.2 Ethicon, Inc. (U.S.) Business Overview
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
11.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.3.5 Ethicon, Inc. (U.S.) Recent Development
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Details
11.4.2 Medtronic (U.S.) Business Overview
11.4.3 Medtronic (U.S.) Obesity Treatment Introduction
11.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.4.5 Medtronic (U.S.) Recent Development
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Details
11.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
11.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2016-2021)
11.5.5 F. Hoffmann-La Roche (Switzerland) Recent Development
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Details
11.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
11.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Development
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Details
11.7.2 Herbalife Ltd. (U.S.) Business Overview
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
11.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.7.5 Herbalife Ltd. (U.S.) Recent Development
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Details
11.8.2 Covidien plc (U.S.) Business Overview
11.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
11.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.8.5 Covidien plc (U.S.) Recent Development
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Details
11.9.2 Apollo Endosurgery (U.S.) Business Overview
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
11.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.9.5 Apollo Endosurgery (U.S.) Recent Development
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Details
11.10.2 Amer Sports (Finland) Business Overview
11.10.3 Amer Sports (Finland) Obesity Treatment Introduction
11.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2016-2021)
11.10.5 Amer Sports (Finland) Recent Development
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Details
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2016-2021)
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Development
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Details
11.12.2 Cybex International (U.S.) Business Overview
11.12.3 Cybex International (U.S.) Obesity Treatment Introduction
11.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.12.5 Cybex International (U.S.) Recent Development
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Details
11.13.2 USGI Medical (U.S.) Business Overview
11.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
11.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.13.5 USGI Medical (U.S.) Recent Development
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Details
11.14.2 Olympus Corporation (Japan) Business Overview
11.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
11.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2016-2021)
11.14.5 Olympus Corporation (Japan) Recent Development
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Details
11.15.2 Brunswick Corporation (U.S.) Business Overview
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
11.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2016-2021)
11.15.5 Brunswick Corporation (U.S.) Recent Development
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Details
11.16.2 Technogym SpA (Italy) Business Overview
11.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
11.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2016-2021)
11.16.5 Technogym SpA (Italy) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Obesity Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical & Implant Devices
Table 3. Key Players of Medication Therapy
Table 4. Key Players of Dietary
Table 5. Key Players of Other
Table 6. Global Obesity Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Obesity Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Obesity Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Obesity Treatment Market Share by Regions (2016-2021)
Table 10. Global Obesity Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Obesity Treatment Market Share by Regions (2022-2027)
Table 12. Obesity Treatment Market Trends
Table 13. Obesity Treatment Market Drivers
Table 14. Obesity Treatment Market Challenges
Table 15. Obesity Treatment Market Restraints
Table 16. Global Obesity Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Obesity Treatment Market Share by Players (2016-2021)
Table 18. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obesity Treatment as of 2020)
Table 19. Ranking of Global Top Obesity Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Obesity Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Obesity Treatment Product Solution and Service
Table 23. Date of Enter into Obesity Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Obesity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Obesity Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Obesity Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Obesity Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Obesity Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Obesity Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Obesity Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Obesity Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Obesity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Obesity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Obesity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Obesity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Obesity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Obesity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Obesity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Obesity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Obesity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Obesity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Obesity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Obesity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Obesity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Obesity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Obesity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Obesity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Obesity Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Obesity Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Obesity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Obesity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Obesity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Obesity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Obesity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Obesity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Obesity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Obesity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Obesity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Obesity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Obesity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Obesity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. NutriSystem, Inc. (U.S.) Company Details
Table 64. NutriSystem, Inc. (U.S.) Business Overview
Table 65. NutriSystem, Inc. (U.S.) Obesity Treatment Product
Table 66. NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 67. NutriSystem, Inc. (U.S.) Recent Development
Table 68. Kellogg Company (U.S.) Company Details
Table 69. Kellogg Company (U.S.) Business Overview
Table 70. Kellogg Company (U.S.) Obesity Treatment Product
Table 71. Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 72. Kellogg Company (U.S.) Recent Development
Table 73. Ethicon, Inc. (U.S.) Company Details
Table 74. Ethicon, Inc. (U.S.) Business Overview
Table 75. Ethicon, Inc. (U.S.) Obesity Treatment Product
Table 76. Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 77. Ethicon, Inc. (U.S.) Recent Development
Table 78. Medtronic (U.S.) Company Details
Table 79. Medtronic (U.S.) Business Overview
Table 80. Medtronic (U.S.) Obesity Treatment Product
Table 81. Medtronic (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 82. Medtronic (U.S.) Recent Development
Table 83. F. Hoffmann-La Roche (Switzerland) Company Details
Table 84. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 85. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product
Table 86. F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 87. F. Hoffmann-La Roche (Switzerland) Recent Development
Table 88. Atkins Nutritionals, Inc. (U.S.) Company Details
Table 89. Atkins Nutritionals, Inc. (U.S.) Business Overview
Table 90. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product
Table 91. Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 92. Atkins Nutritionals, Inc. (U.S.) Recent Development
Table 93. Herbalife Ltd. (U.S.) Company Details
Table 94. Herbalife Ltd. (U.S.) Business Overview
Table 95. Herbalife Ltd. (U.S.) Obesity Treatment Product
Table 96. Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 97. Herbalife Ltd. (U.S.) Recent Development
Table 98. Covidien plc (U.S.) Company Details
Table 99. Covidien plc (U.S.) Business Overview
Table 100. Covidien plc (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 101. Covidien plc (U.S.) Recent Development
Table 102. Apollo Endosurgery (U.S.) Company Details
Table 103. Apollo Endosurgery (U.S.) Business Overview
Table 104. Apollo Endosurgery (U.S.) Obesity Treatment Product
Table 105. Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 106. Apollo Endosurgery (U.S.) Recent Development
Table 107. Amer Sports (Finland) Company Details
Table 108. Amer Sports (Finland) Business Overview
Table 109. Amer Sports (Finland) Obesity Treatment Product
Table 110. Amer Sports (Finland) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 111. Amer Sports (Finland) Recent Development
Table 112. Johnson Health Technology, Ltd. (Taiwan) Company Details
Table 113. Johnson Health Technology, Ltd. (Taiwan) Business Overview
Table 114. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product
Table 115. Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 116. Johnson Health Technology, Ltd. (Taiwan) Recent Development
Table 117. Cybex International (U.S.) Company Details
Table 118. Cybex International (U.S.) Business Overview
Table 119. Cybex International (U.S.) Obesity Treatment Product
Table 120. Cybex International (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 121. Cybex International (U.S.) Recent Development
Table 122. USGI Medical (U.S.) Company Details
Table 123. USGI Medical (U.S.) Business Overview
Table 124. USGI Medical (U.S.) Obesity Treatment Product
Table 125. USGI Medical (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 126. USGI Medical (U.S.) Recent Development
Table 127. Olympus Corporation (Japan) Company Details
Table 128. Olympus Corporation (Japan) Business Overview
Table 129. Olympus Corporation (Japan) Obesity Treatment Product
Table 130. Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 131. Olympus Corporation (Japan) Recent Development
Table 132. Brunswick Corporation (U.S.) Company Details
Table 133. Brunswick Corporation (U.S.) Business Overview
Table 134. Brunswick Corporation (U.S.) Obesity Treatment Product
Table 135. Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 136. Brunswick Corporation (U.S.) Recent Development
Table 137. Technogym SpA (Italy) Company Details
Table 138. Technogym SpA (Italy) Business Overview
Table 139. Technogym SpA (Italy) Obesity Treatment Product
Table 140. Technogym SpA (Italy) Revenue in Obesity Treatment Business (2016-2021) & (US$ Million)
Table 141. Technogym SpA (Italy) Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obesity Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgical & Implant Devices Features
Figure 3. Medication Therapy Features
Figure 4. Dietary Features
Figure 5. Other Features
Figure 6. Global Obesity Treatment Market Share by Application: 2020 VS 2027
Figure 7. Children Case Studies
Figure 8. Adults Case Studies
Figure 9. Obesity Treatment Report Years Considered
Figure 10. Global Obesity Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Obesity Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Obesity Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Obesity Treatment Market Share by Regions (2022-2027)
Figure 14. Global Obesity Treatment Market Share by Players in 2020
Figure 15. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Obesity Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Obesity Treatment Revenue in 2020
Figure 17. Global Obesity Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Obesity Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Obesity Treatment Market Share by Type (2016-2027)
Figure 21. North America Obesity Treatment Market Share by Application (2016-2027)
Figure 22. North America Obesity Treatment Market Share by Country (2016-2027)
Figure 23. United States Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Obesity Treatment Market Share by Type (2016-2027)
Figure 27. Europe Obesity Treatment Market Share by Application (2016-2027)
Figure 28. Europe Obesity Treatment Market Share by Country (2016-2027)
Figure 29. Germany Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Obesity Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Obesity Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Obesity Treatment Market Share by Region (2016-2027)
Figure 39. China Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Obesity Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Obesity Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Obesity Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Obesity Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Obesity Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Obesity Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Obesity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. NutriSystem, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 59. Kellogg Company (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 60. Ethicon, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 61. Medtronic (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 62. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 63. Atkins Nutritionals, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 64. Herbalife Ltd. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 65. Covidien plc (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 66. Apollo Endosurgery (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 67. Amer Sports (Finland) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 68. Johnson Health Technology, Ltd. (Taiwan) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 69. Cybex International (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 70. USGI Medical (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 71. Olympus Corporation (Japan) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 72. Brunswick Corporation (U.S.) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 73. Technogym SpA (Italy) Revenue Growth Rate in Obesity Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の肥満症治療市場 2021：企業別、地域別、種類・用途別 The Obesity Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …- 世界の肥満介入装置市場規模・現状・予測（2021年-2027年） Obesity is a medical condition caused by an increase in fat cells in the body, which can have a negative impact on health. High blood pressure, high cholesterol and heart disease are serious medical conditions associated with obesity. Obesity also increases the risk of certain diseases, such as type…
- 世界の肥満管理市場規模・現状・予測（2021年-2027年） Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed wor…
- 世界の抗肥満薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Drugs (Anti-obesity Medication) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の抗肥満薬市場規模・現状・予測（2021年-2027年） Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. Market Analysis and Insights: Global Anti-obesity Medicine Market The global Anti-obesity Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a …